Analyst Sees No Rival Bids For Auspex Pharmaceuticals
March 31, 2015 at 11:57 AM EDT
Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) won't attract rivals for its $3.2 billion bid for Auspex Pharmaceuticals Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.